Temporary exacerbation of pre-existing psoriasis and eczema in the context of COVID-19 messenger RNA booster vaccination: A case report and review of the literature
Authors:
Open Access
- 18 December 2021
- journal article
- editorial
- Published by Elsevier in JAAD International
- Vol. 6, 94-96
Abstract
No abstract availableKeywords
This publication has 2 references indexed in Scilit:
- Safety Monitoring of an Additional Dose of COVID-19 Vaccine — United States, August 12–September 19, 2021MMWR. Morbidity and Mortality Weekly Report, 2021
- Dermatology patients on biologics and certain other systemic therapies should receive a “booster” messenger RNA COVID-19 vaccine dose: A critical appraisal of recent Food and Drug Administration and Advisory Committee on Immunization Practices recommendationsJournal of the American Academy of Dermatology, 2021